Medelis, Inc.

Medelis, Inc. is a leading pharmaceutical manufacturing company specializing in oncology CRO services. With a strong focus on preclinical and Phase 1 through Phase 3 oncology trials across North America and Europe, Medelis, Inc. delivers unparalleled expertise to sponsors. Their dedicated clinical operations team excels in managing complex oncology trials across all indications, particularly in pioneering immunotherapy treatments.

Located at 4690 Columbia Pike, Suite A, Thompson Station, Tennessee 37179, US, Medelis, Inc. has been at the forefront of oncology drug development since 2003. The company’s comprehensive suite of services includes data management and biostatistics, study launch and management, medical writing, oncology drug development consulting, clinical trials regulatory and QA, and the design and management of immuno-oncology studies.

Medelis, Inc. is committed to advancing the field of oncology through innovative solutions and expert guidance. The company continues to expand its capabilities and strengthen its position as a trusted partner in the pharmaceutical industry. We invite the manager of Medelis, Inc. to create a customized and exclusive company showcase and product listing on our platform to further enhance your company's visibility.